{"entity":{"type":"insider","cik":"0001799363","url":"/insider/0001799363","json_url":"/insider/0001799363.json","name":"Lin Patrick","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":18,"first":"2020-10-05","last":"2026-07-01","span_basis":"filed_date"},"name_variants":[{"name":"Lin Patrick","source":"filing","n_filings":18,"first_seen":"2020-10-05","last_seen":"2026-07-01"}],"transactions":[{"id":6190265,"accession":"0000897069-26-001482","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001482","line_url":"/filing/0000897069-26-001482#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2106.0,"shares_display":"2,106","price_per_share":1.93,"price_display":"1.93","price_state":"stated","total_value":4064.58,"total_display":"4,064.58","total_whole":"4,065","shares_owned_after":13113.0,"shares_owned_after_display":"13,113","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-30","filed_date":"2026-07-01","scope":"insider"},{"id":5761053,"accession":"0000897069-26-001408","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001408","line_url":"/filing/0000897069-26-001408#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1831.0,"shares_display":"1,831","price_per_share":2.22,"price_display":"2.22","price_state":"stated","total_value":4064.82,"total_display":"4,064.82","total_whole":"4,065","shares_owned_after":11007.0,"shares_owned_after_display":"11,007","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-15","filed_date":"2026-06-16","scope":"insider"},{"id":6012852,"accession":"0000897069-26-001289","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001289","line_url":"/filing/0000897069-26-001289#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1582.0,"shares_display":"1,582","price_per_share":2.57,"price_display":"2.57","price_state":"stated","total_value":4065.74,"total_display":"4,065.74","total_whole":"4,066","shares_owned_after":9176.0,"shares_owned_after_display":"9,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-29","filed_date":"2026-06-01","scope":"insider"},{"id":5974570,"accession":"0000897069-26-001182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001182","line_url":"/filing/0000897069-26-001182#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1369.0,"shares_display":"1,369","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":4065.93,"total_display":"4,065.93","total_whole":"4,066","shares_owned_after":7594.0,"shares_owned_after_display":"7,594","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-15","filed_date":"2026-05-19","scope":"insider"},{"id":5768172,"accession":"0000897069-26-001004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-001004","line_url":"/filing/0000897069-26-001004#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1511.0,"shares_display":"1,511","price_per_share":2.69,"price_display":"2.69","price_state":"stated","total_value":4064.59,"total_display":"4,064.59","total_whole":"4,065","shares_owned_after":6236.0,"shares_owned_after_display":"6,236","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-30","filed_date":"2026-05-01","scope":"insider"},{"id":5868510,"accession":"0000897069-26-000908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000908","line_url":"/filing/0000897069-26-000908#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1369.0,"shares_display":"1,369","price_per_share":2.97,"price_display":"2.97","price_state":"stated","total_value":4065.93,"total_display":"4,065.93","total_whole":"4,066","shares_owned_after":4725.0,"shares_owned_after_display":"4,725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-17","scope":"insider"},{"id":5768161,"accession":"0000897069-26-000747","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-26-000747","line_url":"/filing/0000897069-26-000747#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1603.0,"shares_display":"1,603","price_per_share":2.535,"price_display":"2.54","price_state":"stated","total_value":4063.605,"total_display":"4,063.60","total_whole":"4,064","shares_owned_after":3356.0,"shares_owned_after_display":"3,356","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-31","filed_date":"2026-04-01","scope":"insider"},{"id":4788716,"accession":"0000897069-25-000130","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-25-000130","line_url":"/filing/0000897069-25-000130#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":43500.0,"shares_display":"43,500","price_per_share":0.7975,"price_display":"0.80","price_state":"stated","total_value":34691.25,"total_display":"34,691.25","total_whole":"34,691","shares_owned_after":43500.0,"shares_owned_after_display":"43,500","ownership_form":"I","is_10b5_1":null,"transaction_date":"2025-01-27","filed_date":"2025-01-29","scope":"insider"},{"id":2232785,"accession":"0000897069-24-000236","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000897069-24-000236","line_url":"/filing/0000897069-24-000236#line-2","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":2.4,"price_display":"2.40","price_state":"stated","total_value":3600.0,"total_display":"3,600.00","total_whole":"3,600","shares_owned_after":27478.0,"shares_owned_after_display":"27,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-01","filed_date":"2024-02-01","scope":"insider"},{"id":2232782,"accession":"0000897069-24-000236","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000897069-24-000236","line_url":"/filing/0000897069-24-000236#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":2.37,"price_display":"2.37","price_state":"stated","total_value":5925.0,"total_display":"5,925.00","total_whole":"5,925","shares_owned_after":25978.0,"shares_owned_after_display":"25,978","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-31","filed_date":"2024-02-01","scope":"insider"},{"id":6864622,"accession":"0001567619-22-011300","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-011300","line_url":"/filing/0001567619-22-011300#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":1.5945,"price_display":"1.59","price_state":"stated","total_value":3189.0,"total_display":"3,189.00","total_whole":"3,189","shares_owned_after":433390.0,"shares_owned_after_display":"433,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-05-17","filed_date":"2022-05-19","scope":"insider"},{"id":6938357,"accession":"0001567619-22-008312","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001567619-22-008312","line_url":"/filing/0001567619-22-008312#line-2","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":800.0,"shares_display":"800","price_per_share":3.5438,"price_display":"3.54","price_state":"stated","total_value":2835.04,"total_display":"2,835.04","total_whole":"2,835","shares_owned_after":431390.0,"shares_owned_after_display":"431,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-07","filed_date":"2022-04-08","scope":"insider"},{"id":6938355,"accession":"0001567619-22-008312","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-008312","line_url":"/filing/0001567619-22-008312#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1200.0,"shares_display":"1,200","price_per_share":3.1267,"price_display":"3.13","price_state":"stated","total_value":3752.04,"total_display":"3,752.04","total_whole":"3,752","shares_owned_after":430590.0,"shares_owned_after_display":"430,590","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-06","filed_date":"2022-04-08","scope":"insider"},{"id":6937902,"accession":"0001567619-22-000291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-22-000291","line_url":"/filing/0001567619-22-000291#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":429390.0,"shares_owned_after_display":"429,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2022-01-04","scope":"insider"},{"id":4907474,"accession":"0001567619-21-022195","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-022195","line_url":"/filing/0001567619-21-022195#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":12000.0,"total_display":"12,000.00","total_whole":"12,000","shares_owned_after":429390.0,"shares_owned_after_display":"429,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-14","filed_date":"2021-12-16","scope":"insider"},{"id":4907426,"accession":"0001567619-21-021708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-021708","line_url":"/filing/0001567619-21-021708#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3500.0,"shares_display":"3,500","price_per_share":4.7986,"price_display":"4.80","price_state":"stated","total_value":16795.1,"total_display":"16,795.10","total_whole":"16,795","shares_owned_after":426390.0,"shares_owned_after_display":"426,390","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-03","filed_date":"2021-12-07","scope":"insider"},{"id":5227695,"accession":"0001567619-21-016470","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-016470","line_url":"/filing/0001567619-21-016470#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":6.022,"price_display":"6.02","price_state":"stated","total_value":24088.0,"total_display":"24,088.00","total_whole":"24,088","shares_owned_after":422890.0,"shares_owned_after_display":"422,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-26","filed_date":"2021-08-30","scope":"insider"},{"id":5464537,"accession":"0001567619-21-012486","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-21-012486","line_url":"/filing/0001567619-21-012486#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":6.65,"price_display":"6.65","price_state":"stated","total_value":13300.0,"total_display":"13,300.00","total_whole":"13,300","shares_owned_after":401737.0,"shares_owned_after_display":"401,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-21","filed_date":"2021-06-22","scope":"insider"},{"id":9292028,"accession":"0001567619-20-017589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-017589","line_url":"/filing/0001567619-20-017589#line-1","is_derivative":false,"issuer_cik":"0001799363","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001799363","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31250.0,"shares_display":"31,250","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":125000.0,"total_display":"125,000.00","total_whole":"125,000","shares_owned_after":399737.0,"shares_owned_after_display":"399,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider"},{"id":2825998,"accession":"0001567619-20-017572","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001567619-20-017572","line_url":"/filing/0001567619-20-017572#line-1","is_derivative":false,"issuer_cik":"0001533743","issuer_name":"Processa Pharmaceuticals, Inc.","issuer_ticker":"PCSA","issuer_name_source":null,"issuer_url":"/issuer/0001533743","owner_cik":"0001799363","owner_name":"Lin Patrick","owner_display_name":"Lin Patrick","owner_url":"/insider/0001799363","role":"Officer (Chief Business - Strategy Off)","role_mark":"O","role_mark_label":"Officer (Chief Business - Strategy Off)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Business - Strategy Off","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31250.0,"shares_display":"31,250","price_per_share":2.1,"price_display":"2.10","price_state":"stated","total_value":65625.0,"total_display":"65,625.00","total_whole":"65,625","shares_owned_after":399737.0,"shares_owned_after_display":"399,737","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-01","filed_date":"2020-10-05","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":20,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001533743","name":"Processa Pharmaceuticals, Inc.","url":"/issuer/0001533743","role":"Officer (Chief Business - Strategy Off)","n_filings":18,"first_seen":"2020-10-05","last_seen":"2026-07-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001799363","retrieved_at":"2026-08-23T13:01:21+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}